Autoantibody testing in patients with silicone implants.
The preceding evidence suggests that only those women with SBI who develop definite CTD or CTD-like symptoms should be tested for autoantibodies. Women with SBI who develop nonautoimmune diseases or who are asymptomatic should not be tested. These recommendations also apply for subjects with other silicone implants. Until other information becomes available from carefully controlled studies, patients should be evaluated and managed for disease without considering whether he or she has silicone implants.
Sanchez-Guerrero
J
J
Universidad Nacional Autonoma de Mexico, Mexico City, Mexico.
D000974:Antibodies, Antinuclear / Q000032:analysis*; D001327:Autoimmune Diseases / Q000139:chemically induced / Q000276:immunology*; D018427:Breast Implants / Q000009:adverse effects*; D003240:Connective Tissue Diseases / Q000139:chemically induced / Q000276:immunology*; D004247:DNA / Q000276:immunology; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D012216:Rheumatic Diseases / Q000139:chemically induced / Q000276:immunology; D012217:Rheumatoid Factor / Q000032:analysis*; D012828:Silicones / Q000009:adverse effects*
D000974:Antibodies, Antinuclear; D007074:Immunoglobulin G; D012828:Silicones; D004247:DNA; D012217:Rheumatoid Factor